Sanctuary Advisors’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-22,637
Closed -$225K 2460
2025
Q3
$225K Buy
22,637
+1,650
+8% +$17.2K ﹤0.01% 2195
2025
Q2
$208K Buy
20,987
+1,835
+10% +$19.3K ﹤0.01% 2156
2025
Q1
$248K Buy
19,152
+316
+2% +$4.18K ﹤0.01% 1904
2024
Q4
$245K Buy
18,836
+1,109
+6% +$13.4K ﹤0.01% 2125
2024
Q3
$220K Buy
17,727
+1,484
+9% +$16.4K ﹤0.01% 2178
2024
Q2
$182K Buy
+16,243
New +$189K ﹤0.01% 2195

Other funds holding DVAX

Sanctuary Advisors's DVAX Position: Q4 2025 in Review

Sanctuary Advisors sold out of Dynavax Technologies (DVAX) in Q4 2025, closing a stake of 22,637 shares — an estimated $225K sold.

Sanctuary Advisors first reported a position in DVAX in Q2 2024 and held it in 6 quarters. The position peaked at $248K in Q1 2025. 266 funds tracked by Wall St. Rank hold DVAX as of Q4 2025.

  • Sanctuary Advisors reported no remaining Dynavax Technologies position as of Q4 2025 after selling out during the quarter.
  • Sanctuary Advisors sold 22,637 Dynavax Technologies shares in Q4 2025, an estimated $225K.
  • Sanctuary Advisors first reported a position in Dynavax Technologies in Q2 2024 and held it in 6 quarters.
  • Sanctuary Advisors's Dynavax Technologies position peaked at $248K in Q1 2025.
  • 266 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2025.

Based on Sanctuary Advisors's 13F filing for Q4 2025, filed 29 Jan 2026.